Singapore: ScinoPharm will invest NT$1.13 billion (approximately $37.6 million) in the construction of a high potency cy...
Singapore: Taiwan's Department of Health has approved marketing of febuxostat, a novel drug developed for the treatment ...
"Dr Wilber Huang's native intelligence for sales and marketing is among the best I have seen. He has the drive and energ...
